Stem definition | Drug id | CAS RN |
---|---|---|
clofibrate derivatives, peroxisome proliferator activated receptor-alpha(PPAR-alpha) agonists | 5248 | 848259-27-8 |
None
Property | Value | Reference |
---|---|---|
CL (Clearance) | 4.28 mL/min/kg | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
Vd (Volume of distribution) | 0.91 L/kg | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
BA (Bioavailability) | 0.62 % | Kawashima H, Watanabe R, Esaki T, Kuroda M, Nagao C, Natsume-Kitatani Y, Ohashi R, Komura H, Mizuguchi K |
Date | Agency | Company | Orphan |
---|---|---|---|
July 3, 2017 | PMDA | Kowa |
None
None
None
None
None
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Dyslipidemia | indication | 370992007 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 3.58 | acidic |
pKa2 | 1.94 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Peroxisome proliferator-activated receptor alpha | Nuclear hormone receptor | AGONIST | EC50 | 9 | SCIENTIFIC LITERATURE | SCIENTIFIC LITERATURE | |||
Peroxisome proliferator-activated receptor gamma | Nuclear hormone receptor | AGONIST | EC50 | 5.96 | SCIENTIFIC LITERATURE | ||||
Peroxisome proliferator-activated receptor delta | Nuclear hormone receptor | AGONIST | EC50 | 5.80 | SCIENTIFIC LITERATURE |
ID | Source |
---|---|
17VGG92R23 | UNII |
C4547051 | UMLSCUI |
CHEMBL247951 | ChEMBL_ID |
11526038 | PUBCHEM_CID |
DB15212 | DRUGBANK_ID |
D10711 | KEGG_DRUG |
CHEMBL3545412 | ChEMBL_ID |
9692 | INN_ID |
P7F | PDB_CHEM_ID |
C540740 | MESH_SUPPLEMENTAL_RECORD_UI |
None